Answer
Yes, ritlecitinib tosylate (Litfulo) is contraindicated in people with severe hepatic impairment.
Sources for this answer
- Litfulo 50mg hard capsulesPfizer Limited · emc · SmPC §4.3 Contraindications · Version 4Document updated
Sources checked
loading page…